Polycystic Ovary Syndrome Diagnosis Does Not Predict Increased Hidradenitis Suppurativa Disease Severity

A retrospective chart review of 112 female patients at the Einstein/Montefiore HS Center from 2017 to 2022 compared 55 patients with both PCOS and HS to 57 patients with only HS. The study found no significant differences in age, sex, race, HS severity, testosterone levels, hemoglobin A1C, inflammatory markers, or the frequency of core HS therapies prescribed between the two groups. The likelihood of women with HS having PCOS was 2.14 times that of patients without HS. These findings suggest that PCOS does not predict increased HS disease severity, although the study's small sample size and treatment variations are noted limitations.